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The first human rabies case in Chile since 1972 occurred in
March 1996 in a patient without history of known exposure.
Antigenic and genetic characterization of the rabies isolate indi-
cated that its reservoir was the insectivorous bat Tadarida bra-
siliensis. This is the first human rabies case caused by an
insectivorous bat rabies virus variant reported in Latin America.
n Latin America, rabies in bats was suspected during the
1910s in Brazil and was definitively diagnosed for the first
time in Trinidad in 1931 (1,2). Since then, rabies has been
diagnosed in numerous species of nonhematophagous bats
throughout this region (3). Despite these early discoveries, the
important role of nonhematophagous bats in the epidemiology
of the disease remained overshadowed by the presence of
canine and vampire bat rabies in the region (4). During the past
decade, with the control of dog rabies in many urban areas and
the incorporation of antigenic and molecular typing of viral
variants into rabies surveillance programs, an appreciation for
the importance of nonhematophagous bats in rabies epidemiol-
ogy began to emerge in Latin America (5-9). Rabies virus has
been isolated frequently from insectivorous and frugivorous
bats in cities across Latin America (5,10-12). This situation
also characterizes the current epidemiologic pattern of rabies in
Chile, where dog rabies has been controlled. The last human
rabies case in Chile caused by a dog bite occurred in 1972 (5);
since 1985, insectivorous bats have been the main rabies reser-
voirs identified. As such, these bats are the most important
source of infection for the sporadic rabies cases diagnosed in
domestic animals every year (5). In 1996, after a period of 24
years with no known human rabies deaths, the first human
rabies case with an insectivorous bat as the source of infection
was reported in Chile (13).
Case Report
On February 13, 1996, a 7-year-old boy from Doñihue in
Administrative Region VI was admitted to the Hospital Clínico
Fusat of Rancagua in the region (Figure 1) with a 2-day history
of adynamia and dizziness. On admission, the child was calm,
cooperative, and afebrile. Physical examination revealed
anisocoria, ptosis of the left upper eyelid, and strabismus.
There was no sensory loss, but ambulatory difficulties and
abundant sialorrhea were observed. Brain computerized axial
tomography (CAT) scan was normal. Polyradiculoneuritis was
suspected, and gamma globulin was administered intrave-
nously. The presumptive clinical diagnosis was encephalitis.
On February 15, progressive paralysis developed that evolved
to respiratory failure; the boy was connected to a mechanical
ventilator. The patient could still follow simple orders. On
February 18, he lapsed into a coma with severe hypotonia and
total loss of reflexes. CAT scan showed diffuse cerebral
edema, and the electroencephalogram indicated no electric
activity. Intracranial hypertension developed, and the patient
was put under hyperventilation and treated with intravenous
dexamethasone, mannitol, and acyclovir.
Since a virus was considered the most probable cause, lab-
oratory tests were conducted to determine the presence of the
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Figure 1. Map of South America showing the geographic position of
Chile and map of Chile presenting the geographic distribution of the
administrative regions of the country.  aNumber of the corresponding
administrative region. bMetropolitan region.
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following viruses: herpes, measles, Coxsackie, echo, and polio.
All results were negative. Interviews with relatives and the
boy’s nanny revealed that bats had been observed in the fam-
ily’s house. The nanny also reported that she had seen a bat fly-
ing away from the child’s toy box. Even though these
interviews failed to reveal any direct contact with bats or any
history of an animal bite, this epidemiologic information
prompted the physicians to suspect rabies. On February 26,
1996, a serum sample and corneal smear were obtained from
the patient and sent to the Rabies Laboratory of the Instituto de
Salud Pública de Santiago (ISP). A rabies antibody titer of
1:625 was found in the serum specimen by using the indirect
fluorescent-antibody (IFA) technique (14). The patient had no
history of rabies vaccination to account for the presence of
antibodies. The corneal smear was negative for rabies antigen
by the direct fluorescent-antibody (DFA) assay (15). On March
4, a second serum sample, cerebrospinal fluid, and saliva were
obtained. The second serum sample was tested simultaneously
with the first one by IFA assay, and a titer of 1:15,625 was
detected. The cerebrospinal fluid showed a titer of 1:125.
These findings confirmed the presumptive clinical diagnosis of
rabies. The saliva sample was negative by DFA assay and
suckling mouse inoculation (15,16).
The patient died on March 5, 1996, when artificial respira-
tory support was disconnected. Postmortem tissue samples of
cerebral cortex, hippocampus, cerebellum, and nuchal skin
biopsy were sent to the ISP Rabies Laboratory for diagnosis.
The cerebellum and skin specimens were positive for rabies
virus antigen by DFA assay.
Rabies postexposure prophylaxis with the suckling mouse
brain Fuenzalida-Palacios vaccine was administered to the vic-
tim’s mother and to 10 health-care providers who had possible
contact with the patient’s saliva. The rabies postexposure pro-
phylaxis schedule used was 2 mL of vaccine, subcutaneously,
on each of days 1, 2, 3, 4, 5, 6, 21, and 90. Blood samples were
taken from vaccinees on day 14 after the initial dose of vac-
cine; IFA assay showed that adequate immune responses had
developed. 
The virus was isolated from the patient’s brain tissue by
intracerebral inoculation of suckling mice (16). To help iden-
tify the possible source of infection, the virus was antigenically
and genetically characterized. Antigenic characterization of the
virus was carried out by using a panel of eight monoclonal
antibodies directed against the viral nucleoprotein, provided by
the Centers for Disease Control and Prevention. The MAbs
were used in an IFA assay as described (9,17). These analyses
identified a rabies antigenic variant associated with Tadarida
brasiliensis (free-tailed bat) in Chile, which had been desig-
nated as antigenic variant 4 (AgV4) (9,17). 
Genetic characterization was done by sequencing a 320-bp
portion of the rabies virus nucleoprotein gene from nucleotide
position 1,157 to 1,476, as compared with the SADB 19 strain
(18,19). Briefly, genomic viral RNA was extracted from
infected tissue by using TRIzol (Invitrogen, San Diego, CA,
formerly GIBCO-BRL Inc.) according to the manufacturer’s
instructions. Complementary DNA was produced by a reverse
transcription polymerase chain reaction with primers 10 g and
304 (19) and was sequenced by using the Taq Big Dye Termi-
nation Cycle Sequencing Ready Reaction Kit (Applied Biosys-
tems, Foster City, CA), according to the manufacturer’s
protocol, on an Applied Biosystems 377 DNA automated
sequencer (Applied Biosystems).
This human rabies virus isolate was compared with viruses
obtained from domestic animals and insectivorous bats in
urban centers in Chile from 1977 to 1998 (18). PileUp and
Pretty programs of the Wisconsin Package, Version 10
(Genetic Computer Group, 2000, Madison, WI), were used to
produce sequence alignments and comparative nucleotide anal-
yses. The programs DNADIST (Kimura-two parameter),
NEIGHBOR (Neighbor-joining method), and DNAPARS (par-
simony method) from the PHYLIP package, Version 3.5 (20),
were used in the phylogenetic studies. The bootstrap method,
as implemented by the SEQBOOT program from PHYLIP,
was followed by the use of DNADIST and NEIGHBOR for the
distance matrix analyses. SEQBOOT was also used before
employing DNAPARS for the parsimony studies. Graphic
Figure 2. Neighbor-joining tree comparing the human rabies isolate with
representatives of the rabies genetic variants obtained from insectivo-
rous bats and domestic animals in Chile (18). Bootstrap values
obtained from 100 resamplings of the data by using distance matrix
(top) and parsimony methods (bottom) are shown at nodes correspond-
ing to the lineages representing the rabies virus variants (A, B, C, D,
and E) currently circulating in Chile. Only bootstrap values >50% are
shown at the branching points. The bar at the left corner indicates 0.1
nucleotide substitutions per site. aDuvenhage virus, bGenBank acces-
sion number,  cEuropean bat Lyssavirus,  dMyotis chiloensis,  eRoman
numerals indicate the administrative region where the sample was
obtained, fTadarida brasiliensis, gMetropolitan region, hLasiurus borealis.Emerging Infectious Diseases  •  Vol. 8, No. 1, January 2002 81
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representation of the trees was constructed with the TREE-
VIEW program (21).
Although five genetic variants of rabies virus are found in
Chile (18) (Figure 2, groups A to E), a reservoir has been iden-
tified for only two: T. brasiliensis (Figure 2, group D) and
Lasiurus sp. (Figure 2, group E). Phylogenetic analyses of the
Chilean human isolate demonstrated that it segregated in group
D. This group represents the genetic variant of rabies virus
most frequently isolated throughout the country, formed by
viruses from the Metropolitan Region and Regions IV, V, VI,
VII, VIII, IX, and X (Figure 1). The high bootstrap value that
supports the inclusion of this virus in group D and the very
close genetic relationship it has with the other members of this
group (average genetic distance 0.5%) clearly show that  T.
brasiliensis is the likely reservoir of the rabies virus isolated in
this case.
Conclusions
The absence of a history of an animal bite, the clinical pre-
sentation of the disease without the classic signs of hydropho-
bia or aerophobia, and the absence of any human rabies cases
for a period of 24 years in Chile were the primary reasons that
rabies was not first suspected and a definitive diagnosis was
delayed in this case. Retrospective studies of human rabies epi-
demiology have demonstrated that it is not uncommon to
observe rabies cases in which there is no history of a bite,
mainly in situations involving insectivorous bat rabies variants.
For example, of the 17 human rabies cases associated with
insectivorous bats reported in the United States from 1980 to
1996, only one had clear documentation of a bite (22). Without
proper education, patients may not be aware of the risks from a
bat bite. Moreover, the wound may not be appreciated as a con-
cern because of the limited injury inflicted by the bat’s small
teeth (23). Finally, there may not be an opportunity to obtain a
history from a pediatric patient or to discern an exposure that
occurs during sleep or other circumstances (24).
In cases in which a patient shows clinical signs of central
nervous system involvement of unknown or suspected viral
origin, health-care providers should be aware of the importance
of conducting a thorough medical history to appropriately
assess the possibility of rabies. With the important changes in
the epidemiologic patterns of rabies in Latin America, this dis-
ease should be included in the differential diagnosis of neuro-
logic diseases characterized by acute encephalitis and
progressive paralysis, even when no previous history of an ani-
mal bite exists and even in regions where canine rabies has
been eradicated.
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